• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

EBV 驱动的细胞周期进展和致癌的分子机制。

Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis.

机构信息

Medical School, Cancer Research Institute, Key Laboratory of Tumor Cellular and Molecular Pathology of Hunan Province, University of South China, Chang Sheng Xi Avenue 28, Hengyang, 421001, Hunan, People's Republic of China.

Department of Pathology, Central Hospital of Shaoyang, Hunan, China.

出版信息

Med Microbiol Immunol. 2019 Oct;208(5):573-583. doi: 10.1007/s00430-018-0570-1. Epub 2018 Nov 1.

DOI:10.1007/s00430-018-0570-1
PMID:30386928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6746687/
Abstract

The early stage of oncogenesis is linked to the disorder of the cell cycle. Abnormal gene expression often leads to cell cycle disorders, resulting in malignant transformation of human cells. Epstein-Barr virus (EBV) is associated with a diverse range of human neoplasms, such as malignant lymphoma, nasopharyngeal carcinoma and gastric cancer. EBV mainly infects human lymphocytes and oropharyngeal epithelial cells. EBV is latent in lymphocytes for a long period of time, is detached from the cytoplasm by circular DNA, and can integrate into the chromosome of cells. EBV expresses a variety of latent genes during latent infection. The interaction between EBV latent genes and oncogenes leads to host cell cycle disturbances, including the promotion of G/S phase transition and inhibition of cell apoptosis, thereby promoting the development of EBV-associated neoplasms. Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis involve diverse genes and signal pathways. Here, we review the molecular mechanisms of EBV-driven cell cycle progression and promoting oncogenesis.

摘要

肿瘤发生的早期阶段与细胞周期紊乱有关。异常基因表达常导致细胞周期紊乱,从而导致人类细胞的恶性转化。 Epstein-Barr 病毒(EBV)与多种人类肿瘤有关,如恶性淋巴瘤、鼻咽癌和胃癌。EBV 主要感染人类淋巴细胞和口咽上皮细胞。EBV 在淋巴细胞中长期潜伏,通过环状 DNA 从细胞质中分离出来,并可整合到细胞染色体中。EBV 在潜伏感染时表达多种潜伏基因。EBV 潜伏基因与癌基因的相互作用导致宿主细胞周期紊乱,包括促进 G1/S 期转变和抑制细胞凋亡,从而促进 EBV 相关肿瘤的发展。EBV 驱动的细胞周期进展和致癌的分子机制涉及多种基因和信号通路。在这里,我们综述了 EBV 驱动的细胞周期进展和促进致癌的分子机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/a926dc51190d/430_2018_570_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/cbec80e81825/430_2018_570_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/1dfb382a2dc8/430_2018_570_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/a926dc51190d/430_2018_570_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/cbec80e81825/430_2018_570_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/1dfb382a2dc8/430_2018_570_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8350/6746687/a926dc51190d/430_2018_570_Fig3_HTML.jpg

相似文献

1
Molecular mechanisms of EBV-driven cell cycle progression and oncogenesis.EBV 驱动的细胞周期进展和致癌的分子机制。
Med Microbiol Immunol. 2019 Oct;208(5):573-583. doi: 10.1007/s00430-018-0570-1. Epub 2018 Nov 1.
2
Latency and lytic replication in Epstein-Barr virus-associated oncogenesis.潜伏期和溶原性复制在 EBV 相关肿瘤发生中的作用。
Nat Rev Microbiol. 2019 Nov;17(11):691-700. doi: 10.1038/s41579-019-0249-7. Epub 2019 Sep 2.
3
EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.鼻咽癌中的EB病毒感染与糖代谢
Adv Exp Med Biol. 2017;1018:75-90. doi: 10.1007/978-981-10-5765-6_6.
4
Modes of infection and oncogenesis by the Epstein-Barr virus.EB 病毒的感染和致癌模式。
Rev Med Virol. 2014 Jul;24(4):242-53. doi: 10.1002/rmv.1786. Epub 2014 Feb 28.
5
[Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].[爱泼斯坦-巴尔病毒介导的肿瘤发生机制]
Gan To Kagaku Ryoho. 2015 Oct;42(10):1133-6.
6
Viral Carcinogenesis Beyond Malignant Transformation: EBV in the Progression of Human Cancers.超越恶性转化的病毒致癌作用:EB病毒在人类癌症进展中的作用
Trends Microbiol. 2016 Aug;24(8):649-664. doi: 10.1016/j.tim.2016.03.008. Epub 2016 Apr 7.
7
Epstein-Barr Virus (EBV): infection, propagation, quantitation, and storage.爱泼斯坦-巴尔病毒(EBV):感染、增殖、定量及保存
Curr Protoc Microbiol. 2007 Aug;Chapter 14:Unit 14E.2. doi: 10.1002/9780471729259.mc14e02s6.
8
The biology of EBV infection in human epithelial cells.人类上皮细胞中 EBV 感染的生物学。
Semin Cancer Biol. 2012 Apr;22(2):137-43. doi: 10.1016/j.semcancer.2012.02.004.
9
Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.EBNA1的癌风险变体可解除爱泼斯坦-巴尔病毒游离体潜伏期的调控。
Oncotarget. 2017 Jan 31;8(5):7248-7264. doi: 10.18632/oncotarget.14540.
10
Activation of the FGFR1 signalling pathway by the Epstein-Barr virus-encoded LMP1 promotes aerobic glycolysis and transformation of human nasopharyngeal epithelial cells.爱泼斯坦-巴尔病毒编码的LMP1对FGFR1信号通路的激活促进了人鼻咽上皮细胞的有氧糖酵解和转化。
J Pathol. 2015 Oct;237(2):238-48. doi: 10.1002/path.4575. Epub 2015 Aug 3.

引用本文的文献

1
Epstein-barr virus (EBV) in cervical carcinoma detected by in situ hybridization targeting ebers and the viral genome.通过靶向EBERs和病毒基因组的原位杂交检测宫颈癌中的爱泼斯坦-巴尔病毒(EBV)
Braz J Microbiol. 2025 Sep 16. doi: 10.1007/s42770-025-01774-y.
2
Epstein-Barr virus-driven molecular pathogenesis of primary pulmonary lymphoepithelial carcinoma.爱泼斯坦-巴尔病毒驱动的原发性肺淋巴上皮癌的分子发病机制
Front Oncol. 2025 Aug 13;15:1630415. doi: 10.3389/fonc.2025.1630415. eCollection 2025.
3
Advances in Epstein-Barr Virus Detection: From Traditional Methods to Modern Technologies.

本文引用的文献

1
Upregulation of the Chemokine Receptor CCR2B in Epstein‒Barr Virus-Positive Burkitt Lymphoma Cell Lines with the Latency III Program.上调 III 型潜伏 Epstein‒Barr 病毒阳性 Burkitt 淋巴瘤细胞系趋化因子受体 CCR2B。
Viruses. 2018 May 3;10(5):239. doi: 10.3390/v10050239.
2
EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.EBNA1:致癌活性、免疫逃逸及生化功能为针对爱泼斯坦-巴尔病毒相关癌症的新型治疗策略提供靶点。
Cancers (Basel). 2018 Apr 6;10(4):109. doi: 10.3390/cancers10040109.
3
Outlooks on Epstein-Barr virus associated gastric cancer.
爱泼斯坦-巴尔病毒检测的进展:从传统方法到现代技术
Viruses. 2025 Jul 22;17(8):1026. doi: 10.3390/v17081026.
4
Induction chemoradiotherapy achieves long-term recurrence-free survival in locally advanced pulmonary lymphoepithelioma-like carcinoma: a case report and literature review.诱导放化疗使局部晚期肺淋巴上皮瘤样癌实现长期无复发生存:一例报告及文献综述
Front Immunol. 2025 Jul 31;16:1605900. doi: 10.3389/fimmu.2025.1605900. eCollection 2025.
5
Oncoviruses in the Oral Cavity: Recent Advances in Understanding Viral Infections and Tumorigenesis.口腔中的肿瘤病毒:病毒感染与肿瘤发生认识的最新进展
Int J Mol Sci. 2025 Jul 13;26(14):6721. doi: 10.3390/ijms26146721.
6
Extensive hepatic metastases from combined Epstein-Barr virus infection with acute hepatic failure in small cell lung cancer: A case report.小细胞肺癌合并爱泼斯坦-巴尔病毒感染致急性肝衰竭伴广泛肝转移:一例报告
Medicine (Baltimore). 2025 Jun 20;104(25):e42991. doi: 10.1097/MD.0000000000042991.
7
Inhibitory effect of recombinant BCG containing the fusion gene BFNA on EB virus-positive tumors.含融合基因BFNA的重组卡介苗对EB病毒阳性肿瘤的抑制作用。
Appl Microbiol Biotechnol. 2025 Jun 3;109(1):134. doi: 10.1007/s00253-025-13528-9.
8
Viral oncogenesis in cancer: from mechanisms to therapeutics.癌症中的病毒致癌作用:从机制到治疗
Signal Transduct Target Ther. 2025 May 12;10(1):151. doi: 10.1038/s41392-025-02197-9.
9
Lung cancer in young individuals; risk factors and epidemiology.年轻个体中的肺癌;危险因素与流行病学
J Thorac Dis. 2025 Mar 31;17(3):1746-1754. doi: 10.21037/jtd-2024-1950. Epub 2025 Mar 21.
10
Anti-Epstein-Barr Virus Activities of Flavones and Flavonols with Effects on Virus-Related Cancers.黄酮类和黄酮醇类化合物的抗爱泼斯坦-巴尔病毒活性及其对病毒相关癌症的影响
Molecules. 2025 Feb 26;30(5):1058. doi: 10.3390/molecules30051058.
埃克斯坦巴尔病毒相关胃癌的展望。
Cancer Treat Rev. 2018 May;66:15-22. doi: 10.1016/j.ctrv.2018.03.006. Epub 2018 Mar 31.
4
Significance of circulating Epstein-Barr virus DNA monitoring after remission in patients with extranodal natural killer T cell lymphoma.结外自然杀伤/T 细胞淋巴瘤患者缓解后循环 EBV DNA 监测的意义。
Ann Hematol. 2018 Aug;97(8):1427-1436. doi: 10.1007/s00277-018-3313-x. Epub 2018 Apr 8.
5
Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.爱泼斯坦-巴尔病毒作为鼻咽癌治疗中一个有前景的免疫治疗靶点。
J Pathog. 2017;2017:7349268. doi: 10.1155/2017/7349268. Epub 2017 Dec 31.
6
Epstein-Barr virus nuclear antigen EBNA-LP is essential for transforming naïve B cells, and facilitates recruitment of transcription factors to the viral genome.爱泼斯坦-巴尔病毒核抗原 EBNA-LP 对于转化初始 B 细胞是必不可少的,并有助于转录因子募集到病毒基因组。
PLoS Pathog. 2018 Feb 20;14(2):e1006890. doi: 10.1371/journal.ppat.1006890. eCollection 2018 Feb.
7
Epstein-Barr Virus (EBV) Latent Protein EBNA3A Directly Targets and Silences the Gene in B Cells Infected by EBV.爱泼斯坦-巴尔病毒(EBV)潜伏蛋白EBNA3A直接靶向并沉默受EBV感染的B细胞中的基因。
J Virol. 2018 Mar 14;92(7). doi: 10.1128/JVI.01918-17. Print 2018 Apr 1.
8
EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma.EBV 编码的 microRNAs 靶向鼻咽癌中的 ATM 介导的反应。
J Pathol. 2018 Apr;244(4):394-407. doi: 10.1002/path.5018. Epub 2018 Feb 16.
9
EBV latent membrane protein 2A orchestrates p27 degradation via Cks1 to accelerate MYC-driven lymphoma in mice.EB病毒潜伏膜蛋白2A通过Cks1蛋白调控p27降解,从而加速小鼠中MYC驱动的淋巴瘤发展。
Blood. 2017 Dec 7;130(23):2516-2526. doi: 10.1182/blood-2017-07-796821. Epub 2017 Oct 26.
10
Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway.EB 病毒 miR-BART6-3p 抑制 RIG-I 通路。
J Innate Immun. 2017;9(6):574-586. doi: 10.1159/000479749. Epub 2017 Sep 7.